HLA Class I Rabbit Polyclonal Antibody

HLA Class I Rabbit Polyclonal Antibody

规格:20μL 价格:¥600
规格:50μL 价格:¥1200
规格:100μL 价格:¥2150
应用(Application):WB,ELISA

种属(Reactivity):Human
偶联物(Conjugate):Unconjugated
基因名(Gene Name):HLA-A HLAA
SKU: APRab12078 Category: 兔多克隆抗体 Tags: , , , , ,

说明书 复制

产品概述

产品名称(Product Name)

HLA Class I Rabbit Polyclonal Antibody

描述(Description)

Rabbit polyclonal Antibody

宿主(Host)

Rabbit

应用(Application)

WB,ELISA

种属反应性(Reactivity)

Human

 

产品性能

偶联物(Conjugation)

Unconjugated

修饰(Modification)

Unmodified

同种型(Isotype)

IgG

克隆(Clonality)

Polyclonal

形式(Form)

Liquid

存放说明(Storage)

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

储存溶液(Buffer)

Liquid in PBS containing 50% glycerol, 0.5% protective protein and 0.02% New type preservative N.

纯化方式(Purification)

Affinity purification

 

免疫原

基因名(Gene Name)

HLA-A HLAA

别名(Alternative Names)

HLA-A HLAA

基因ID(Gene ID)

蛋白ID(SwissProt ID)

P01891/P01892/P04439/P05534/P10314/P10316/P13746/P16189/P18462/P30443/P30450/P30453/P30455/P30456/P30457/P30512/Q09160

 

产品应用

稀释比(Dilution Ratio)

WB 1:500-1:2000,ELISA 1:10000-1:20000

蛋白分子量(Molecular Weight)

40kDa

 

研究背景

HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transfunction:Involved in the presentation of foreign antigens to the immune system.,polymorphism:The following alleles of A-1 are known: A*0101, A*0102, A*0103, A*0106 and A*0107. The sequence shown is that of A*0101.,polymorphism:The following alleles of A-11 are known: A*1101 (A-11E), A*1102 (A-11K), A*1103, A*1104, A*1105 and A*1107. The sequence shown is that of A*1101.,polymorphism:The following alleles of A-2 are known: A*0201, A*0202, A*0203, A*0204, A*0205, A*0206 (A2.4A), A*0207, A*0208, A*0209, A*0210, A*0211 (A2.5), A*0212, A*0213 (A*02SLU), A*0216, A*0217, A*0218 (A2K), A*0219, A*0220, A*0221, A*0231, A*0234 (A*AAT), A*0235, A*0236 and A*0237. The sequence shown is that of A*0201.,polymorphism:The following alleles of A-23 are known: A*2301, A*2302, A*2303, A*2304 and A*2305. The sequence shown is that of A*2301.,polymorphism:The following alleles of A-24 are known: A*2401, A*2402, A*2403, A*2406, A*2408 (A9HH), A*2410 (A*24JV), A*2413 (A*24YM), A*2414 (A*24SA) and A*2429. Allele A*2402 is represented in all major racial groups. Allele A*2406 and allele A*2413 are found in the Australian Aborigenal population. Allele A*2414 is found in individuals of South American descent. The sequence shown is that of A*2402.,polymorphism:The following alleles of A-25 are known: A*2501 A*2502 and A*2503. The sequence shown is that of A*2501.,polymorphism:The following alleles of A-26 are known: A*2601, A*2602, A*2603, A*2604 (A-10SA), A*2605, A*2607, A*2608, A*2612 and A*2615. The sequence shown is that of A*2601.,polymorphism:The following alleles of A-29 are known: A*2901 (A29.1), A*2902 (A29.2), A*2903 and A*2904. The sequence shown is that of A*2901.,polymorphism:The following alleles of A-3 are known: A*0301 (A-3.1), A*0302, A*0304 and A*0305. The sequence shown is that of A*0301.,polymorphism:The following alleles of A-31 are known: A*3101, A*3102, A*3103, A*3104, A*3105 (A3101v1) and A*3106. The sequence shown is that of A*3101.,polymorphism:The following alleles of A-32 are known: A*3201, A*3202, A*3203, A*3204, A*3205 and A*3206. The sequence shown is that of A*3201.,polymorphism:The following alleles of A-34 are known: A*3401 (Aw-34.1) and A*3402 (Aw-34.2). The sequence shown is that of A*3401.,polymorphism:The following alleles of A-36 are known: A*3601 and A*3602. The sequence shown is that of A*3601.,polymorphism:The following alleles of A-66 are known: A*6601 and A*6602 (Aw67). The sequence shown is that of A*6601.,polymorphism:The following alleles of A-68 are known: A*6801 (Aw68.1), A*6802, A*6803. A*6804, A*6805, A*6806, A*6807, A*6808, A*6809, A*6810, A*6816 and A*6817. The sequence shown is that of A*6801.,polymorphism:The only allele of A-43 known is A*4301 which is shown here.,polymorphism:The only allele of A-69 known is A*6901 which is shown here.,polymorphism:The only allele of A-80 known is A*8001 which is shown here.,PTM:Polyubiquitinated in a post ER compartment by interaction with human herpesvirus 8 MIR1 protein. This targets the protein for rapid degradation via the ubiquitin system.,PTM:Polyubiquitinated in a post ER compartment through interaction with human herpesvirus 8 MIR1 protein. This targets the protein for rapid degradation via the ubiquitin system.,PTM:Sulfated. Polyubiquitinated in a post ER compartment through interaction with human herpesvirus 8 MIR1 protein. This targets the protein for rapid degradation via the ubiquitin system.,sequence caution:The sequence differs from that shown extensively.,similarity:Belongs to the MHC class I family.,similarity:Contains 1 Ig-like C1-type (immunoglobulin-like) domain.,subunit:Dimer of alpha chain and a beta chain (beta-2-microglobulin). Interacts with human herpesvirus 8 MIR1 protein.,subunit:Dimer of alpha chain and a beta chain (beta-2-microglobulin). Interacts with human herpesvirus 8 MIR1 protein. Interacts with HTLV-1 accessory protein p12I.,subunit:Heterodimer of an alpha chain and a beta chain (beta-2-microglobulin). Interacts with human herpesvirus 8 MIR1 protein.,

 

研究领域

Endocytosis;Cell adhesion molecules (CAMs);Antigen processing and presentation;Natural killer cell mediated cytotoxicity;Type I diabetes mellitus;Autoimmune thyroid disease;Allograft rejection;Graft-versus-host disease;Viral myocarditis;


  • 027-87002838

  • order@enkilife.cn

  • 微信客服
  • 企业微信
  • 在线留言
    关闭